AKTUAL'NOST' RANNEY DIAGNOSTIKI PANIChESKOGO RASSTROYSTVA VRAChAMI OBShchEY PRAKTIKI. PRAM V TERAPII PANIChESKIKh SOSTOYaNIY
- Authors: Gorodnichev A.V1
-
Affiliations:
- Issue: No 4s (2012)
- Pages: 10-15
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/279379
- ID: 279379
Cite item
Open Access
Access granted
Abstract
Panic disorder (PD) is one of the most common diseases among the spectrum of anxiety disorders. Selective serotonin reuptake inhibitors now are recognized as drugs of first choice in the treatment of PD. Their high efficiency combines with a favorable tolerability profile. Tricyclic antidepressants, benzodiazepines, and cognitive-behavioral therapy also play an important role at various stages of treatment of PD.
Full Text
References
- Weissman M.M. The epidemiology of anxiety disorders: rates, risks and familian patterns. J Psychiat Res 1988; 2(1): 99-114.
- Schumacher J., Kristensen A.S., Wendland J.R., et al. The genetics of panic disorder. J Med Genet 2011; 48(6): 361-68.
- Вейн А.М., Дюкова Г.М., Воробьева О.В. и др. Панические атаки. Руководство для врачей. М., 2004.
- Mathew S.J., Price R.B., Charney D.S. Recent advances in the neurobiology of anxiety disorders: implications for novel therapeutics. Am J Med Genet C Semin Med Genet 2008; 148: 89-98.
- Middeldorp C.M., Birley A.J., Cath D.C. Familial clustering of major depression and anxiety disorders in Australian and Dutch twins and siblings. Twin Res Hum Genet 2005; 8: 609-15.
- Kendler K.S., Gardner C.O., Prescott C.A. Panic syndromes in a population-based sample of male and female twins. Psychol Med 2001; 31: 989-1000.
- Scherrer J.F., True W.R., Xian H. Evidence for genetic influences common and specific to symptoms of generalized anxiety and panic. J Affect Disord 2000; 57: 25-35.
- Tsuang M., Domschke K., Jerskey B.A. Agoraphobic behavior and panic attack: a study of male twins. J Anxiety Disord 2004; 18: 799-807.
- Воробьева О.В. Панические атаки. Клиника, диагностика, принципы лечения. М, 2009. С. 7.
- Sheehan D.V. The management of panic disorder. J Clin Psychiatry. 2002; 63(14): 17-21.
- WHO. Programme on substance abuse. Rational use benzodiazepines. 1996.
- Мосолов С.Н. Клиническое применение антидепрессантов. СПб., 1995. С. 384.
- Wade A.G., Lepola U., Koponen H.J., et al. The effect of citalopram in panic disorder. Br J Psychiatry 1997; 170: 549-53.
- Amore M., Magnani K., Cerisoli M., et al. Panic disorder. A long-term treatment study: Fluoxetine vs imipramine. Hum Psychopharmacol Clin Exp 1999; 14: 429-34.
- Ястребов Д.В., Использование циталопрама для терапии аффективных и тревожных расстройств: обзор литературы и оценка эффективности препарата Прам в клинике пограничных состояний // Фарматека 2010. № 7. С. 19-26.
- Noyes R. Jr., Burrows G.D., Reich J.H., et al. Diazepam versus alprazolam for the treatment of panic disorder. J Clin Psychiatry 1996; 57(8): 349-55.
- Goddard A.W., Brouette T., Almai A., et al. Early coadministration of clonazepam with sertraline for panic disorder. Arch Gen Psychiatry 2001; 58: 681-86.
- Pollack M.H., Allgulander C., Bandelow B., et al. WCA recommendations for the longterm treatment of panic disorder. CNS Spectr. 2003; 8(1): 17-30.
- Barlow D.H., Gorman J.M., Shear M.K., Woods S.W. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial. JAMA. 2000; 283(19): 2529-36.
Supplementary files
